3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Philadelphia Chromosome
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Recurrence
1
Peritoneal Neoplasms
1
Myeloproliferative Disorders
1
Leukemia
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
3
Doxorubicin
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
selinexor
1
ribociclib
1
peposertib
1
pazopanib
1
palbociclib
1
mirdametinib
1
liposomal doxorubicin
1
abemaciclib
1
X-Rays
1
Surgical Procedures, Operative
1
Radiotherapy
1
Radiation
1
Proton Therapy
1
Neoadjuvant Therapy
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Everolimus
1
Biopsy
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
nilotinib
×
30 days
×
Clear all
No trials found.